文献速递传染病防控与疫情报告免疫规划

全球脊髓灰质炎消灭进展(2017年1月至2019年3月)

Progress Toward Polio Eradication - Worldwide, January 2017-March 2019.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2019-05-24

本报告描述了2017年1月1日至2019年3月31日全球脊髓灰质炎消灭进展。阿富汗和巴基斯坦2017年报告WPV病例数最低(22例),但2018年报告33例WPV1病例;2019年1-3月全球报告12例WPV1病例,比2018年同期多4例。2017-2019年(截至5月3日)8个国家报告210例cVDPV病例。补充免疫活动覆盖儿童、获取高危流动人群和监测性能差异是持续挑战。

要点

  • 2017年阿富汗和巴基斯坦WPV病例数最低(22例),2018年增至33例WPV1病例。
  • 2019年1-3月全球报告12例WPV1病例,较2018年同期增加4例。
  • 2017-2019年8个国家报告210例cVDPV病例,与OPV覆盖率低有关。

核心结论

  • 全球脊髓灰质炎消灭取得进展,但阿富汗和巴基斯坦WPV1传播持续,cVDPV疫情构成挑战。

研究设计与样本

  • 基于全球脊髓灰质炎监测数据的描述性分析,覆盖2017年1月1日至2019年3月31日。

主要发现

  • 阿富汗和巴基斯坦2017年报告WPV病例数最低(22例),2018年报告33例WPV1病例。
  • 2019年1-3月(截至5月3日)全球报告12例WPV1病例,比2018年同期(8例)多4例。
  • 2017-2019年(截至5月3日)8个国家报告210例cVDPV病例。

临床怎么用

  • 在补充免疫活动中覆盖儿童、获取高危流动人群,并加强阿富汗和巴基斯坦之间的协调。
  • 针对cVDPV疫情需加强规划改进以迅速阻断传播并限制未来疫情风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since the Global Polio Eradication Initiative (GPEI) began in 1988, transmission of wild poliovirus (WPV) has been interrupted in all countries except Afghanistan, Nigeria, and Pakistan. WPV type 2 (WPV2) was declared eradicated in 2015; WPV type 3 has not been detected since 2012 (1). After the certification of the eradication of WPV2, a global switch from trivalent oral poliovirus vaccine (tOPV, containing vaccine virus types 1, 2, and 3) to bivalent oral poliovirus vaccine (bOPV, containing types 1 and 3) was completed in April 2016. Nigeria last reported WPV type 1 (WPV1) cases in 2016. This report describes global progress toward poliomyelitis eradication during January 1, 2017-March 31, 2019, and updates previous reports (1,2). Afghanistan and Pakistan reported their lowest annual number of WPV cases (22) in 2017; however, 33 WPV1 cases were reported in 2018. During January-March 2019 (as of May 3), 12 WPV1 cases had been reported worldwide, four more than the eight reported during the corresponding period in 2018. The occurrence of polio cases caused by circulating vaccine-derived poliovirus (cVDPV) is rare and occurs where oral poliovirus vaccine (OPV) coverage has been low and vaccine virus reverts to neurovirulence (3). Eight countries (Democratic Republic of the Congo [DRC], Indonesia, Mozambique, Niger, Nigeria, Papua New Guinea, Somalia, and Syria) reported 210 cVDPV cases during 2017-2019 (as of May 3). Reaching children during supplemental immunization activities (SIAs), accessing mobile populations at high risk, and variations in surveillance performance represent ongoing challenges. Innovative efforts to vaccinate every child and strengthen coordination efforts between Afghanistan and Pakistan will help achieve eradication. For cVDPV outbreak responses to promptly stop transmission, intensified programmatic improvements are needed to make the responses more effective and limit the risk for generating future outbreaks.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Greene SA, Ahmed J, Datta SD, et al. Progress Toward Polio Eradication - Worldwide, January 2017-March 2019. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31120868. doi:10.15585/mmwr.mm6820a3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。